Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Ball ED, Bolwell BJ, Bunin NJ, Cheerva A, Delgado DC, Dvorak CC, Gillio AP, Hahn TE, Hale GA, Haight AE, Hayes-Lattin BM, Kasow KA, Linenberger M, Magalhaes-Silverman M, Mori S, Prasad VK, Quigg TC, Sahdev I, Schriber JR, Shenoy S, Tse WT, Yanik GA, Navarro WH, Horowitz MM, Confer DL, Shaw BE, Switzer GE.

Biol Blood Marrow Transplant. 2018 Dec 31. pii: S1083-8791(18)31698-7. doi: 10.1016/j.bbmt.2018.12.765. [Epub ahead of print]

PMID:
30605731
2.

Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.

Pulsipher MA, Logan BR, Chitphakdithai P, Kiefer DM, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Varni JW, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Bunin NJ, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Shaw BE, Confer DL.

Biol Blood Marrow Transplant. 2018 Nov 10. pii: S1083-8791(18)30698-0. doi: 10.1016/j.bbmt.2018.11.004. [Epub ahead of print]

PMID:
30423480
3.

Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at 1-year compared to unrelated donors.

Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman SF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE.

Haematologica. 2018 Oct 31. pii: haematol.2018.200121. doi: 10.3324/haematol.2018.200121. [Epub ahead of print]

4.

Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma.

Tageja N, Korde N, Kazandjian D, Panch S, Manasanch E, Bhutani M, Kwok M, Mailankody S, Yuan C, Stetler-Stevenson M, Leitman SF, Sportes C, Landgren O.

Bone Marrow Transplant. 2018 Nov;53(11):1445-1449. doi: 10.1038/s41409-018-0170-0. Epub 2018 May 4.

PMID:
29728700
5.

Transfused neutrophils home to a joint with fungal infection.

Ward DC, Beaulieu GP, Leitman SF, Flegel WA.

Transfusion. 2016 Nov;56(11):2655-2656. doi: 10.1111/trf.13743. No abstract available.

6.

Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.

Hickey BW, Lumsden JM, Reyes S, Sedegah M, Hollingdale MR, Freilich DA, Luke TC, Charoenvit Y, Goh LM, Berzins MP, Bebris L, Sacci JB Jr, De La Vega P, Wang R, Ganeshan H, Abot EN, Carucci DJ, Doolan DL, Brice GT, Kumar A, Aguiar J, Nutman TB, Leitman SF, Hoffman SL, Epstein JE, Richie TL.

Malar J. 2016 Jul 22;15(1):377. doi: 10.1186/s12936-016-1435-y.

7.

Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.

Panch SR, Yau YY, Fitzhugh CD, Hsieh MM, Tisdale JF, Leitman SF.

Transfusion. 2016 May;56(5):1058-65. doi: 10.1111/trf.13551.

8.

The impact of leukapheresis on immune-cell number and function in patients with advanced cancer.

Gulley JL, Marté J, Heery CR, Madan RA, Steinberg SM, Leitman SF, Tsang KY, Schlom J.

Cancer Immunol Immunother. 2015 Nov;64(11):1429-35. doi: 10.1007/s00262-015-1738-9. Epub 2015 Aug 5.

PMID:
26243387
9.

Ask about ice, then consider iron.

Rabel A, Leitman SF, Miller JL.

J Am Assoc Nurse Pract. 2016 Feb;28(2):116-20. doi: 10.1002/2327-6924.12268. Epub 2015 May 5.

10.

Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience.

Kadri SS, Remy KE, Strich JR, Gea-Banacloche J, Leitman SF.

Transfusion. 2015 Sep;55(9):2076-85. doi: 10.1111/trf.13099. Epub 2015 Apr 9. Review.

11.

Transfusion medicine illustrated: Muddy waters in therapeutic plasma exchange.

West KA, Leitman SF, Flegel WA.

Transfusion. 2014 Sep;54(9):2157. doi: 10.1111/trf.12601. No abstract available.

12.

Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.

Panch SR, Yau YY, West K, Diggs K, Sweigart T, Leitman SF.

Transfusion. 2015 Mar;55(3):611-22. doi: 10.1111/trf.12854. Epub 2014 Sep 11.

13.

Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.

Panch SR, Yau YY, Kang EM, De Ravin SS, Malech HL, Leitman SF.

Transfusion. 2015 Feb;55(2):265-74. doi: 10.1111/trf.12830. Epub 2014 Aug 21.

14.

Hemochromatosis: the new blood donor.

Leitman SF.

Hematology Am Soc Hematol Educ Program. 2013;2013:645-50. doi: 10.1182/asheducation-2013.1.645. Review.

PMID:
24319245
15.

Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSF.

Lundqvist A, Smith AL, Takahashi Y, Wong S, Bahceci E, Cook L, Ramos C, Tawab A, McCoy JP Jr, Read EJ, Khuu HM, Bolan CD, Joo J, Geller N, Leitman SF, Calandra G, Dunbar C, Kurlander R, Childs RW.

J Immunol. 2013 Dec 15;191(12):6241-9. doi: 10.4049/jimmunol.1301148. Epub 2013 Nov 15.

16.

Health-related quality of life of bone marrow versus peripheral blood stem cell donors: a prespecified subgroup analysis from a phase III RCT-BMTCTN protocol 0201.

Switzer GE, Bruce JG, Harrington D, Haagenson M, Drexler R, Foley A, Confer D, Bishop M, Anderlini P, Rowley S, Leitman SF, Anasetti C, Wingard JR.

Biol Blood Marrow Transplant. 2014 Jan;20(1):118-27. doi: 10.1016/j.bbmt.2013.10.024. Epub 2013 Nov 1.

17.

Systemic hypersensitivity reaction mimicking anaphylaxis after first filgrastim administration in a healthy donor.

Tholpady A, Chiosea I, Lyons JJ, Baird K, Leitman SF.

Transfusion. 2013 May;53(5):1146-7. doi: 10.1111/trf.12149. No abstract available.

18.

Intermittent leukocytosis in an asymptomatic platelet donor.

Panch SR, Riordan MM, Miranda SJ, Leitman SF.

Transfusion. 2013 May;53(5):1144-6. doi: 10.1111/trf.12155. No abstract available.

19.

Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.

Fowler DH, Mossoba ME, Steinberg SM, Halverson DC, Stroncek D, Khuu HM, Hakim FT, Castiello L, Sabatino M, Leitman SF, Mariotti J, Gea-Banacloche JC, Sportes C, Hardy NM, Hickstein DD, Pavletic SZ, Rowley S, Goy A, Donato M, Korngold R, Pecora A, Levine BL, June CH, Gress RE, Bishop MR.

Blood. 2013 Apr 11;121(15):2864-74. doi: 10.1182/blood-2012-08-446872. Epub 2013 Feb 20.

20.

Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome.

Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF.

Transfusion. 2013 Aug;53(8):1637-44. doi: 10.1111/trf.12061. Epub 2013 Jan 10.

21.

Capillary versus venous haemoglobin determination in the assessment of healthy blood donors.

Patel AJ, Wesley R, Leitman SF, Bryant BJ.

Vox Sang. 2013 May;104(4):317-23. doi: 10.1111/vox.12006. Epub 2013 Jan 7.

22.

Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program.

Pulsipher MA, Chitphakdithai P, Logan BR, Shaw BE, Wingard JR, Lazarus HM, Waller EK, Seftel M, Stroncek DF, Lopez AM, Maharaj D, Hematti P, O'Donnell PV, Loren AW, Leitman SF, Anderlini P, Goldstein SC, Levine JE, Navarro WH, Miller JP, Confer DL.

Blood. 2013 Jan 3;121(1):197-206. doi: 10.1182/blood-2012-03-417667. Epub 2012 Oct 29. Erratum in: Blood. 2014 Mar 20;123(12):1970.

23.

Peripheral-blood stem cells versus bone marrow from unrelated donors.

Anasetti C, Logan BR, Lee SJ, Waller EK, Weisdorf DJ, Wingard JR, Cutler CS, Westervelt P, Woolfrey A, Couban S, Ehninger G, Johnston L, Maziarz RT, Pulsipher MA, Porter DL, Mineishi S, McCarty JM, Khan SP, Anderlini P, Bensinger WI, Leitman SF, Rowley SD, Bredeson C, Carter SL, Horowitz MM, Confer DL; Blood and Marrow Transplant Clinical Trials Network.

N Engl J Med. 2012 Oct 18;367(16):1487-96. doi: 10.1056/NEJMoa1203517.

24.

Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusion.

Bat T, Leitman SF, Calvo KR, Chauvet D, Dunbar CE.

Transfusion. 2013 Jun;53(6):1201-4. doi: 10.1111/j.1537-2995.2012.03918.x. Epub 2012 Oct 9.

25.

Re: interdisciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer.

Gulley JL, Leitman SF, Dahut W, Schlom J.

J Natl Cancer Inst. 2012 Jul 18;104(14):1106; author reply 1109-12. doi: 10.1093/jnci/djs280. No abstract available.

PMID:
22825555
26.

Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Shizukuda Y, Smith KP, Tripodi DJ, Arena R, Yau YY, Bolan CD, Waclawiw MA, Leitman SF, Rosing DR.

Am J Phys Med Rehabil. 2012 May;91(5):418-24. doi: 10.1097/PHM.0b013e3182465f5f.

27.

Iron replacement therapy in the routine management of blood donors.

Bryant BJ, Yau YY, Arceo SM, Daniel-Johnson J, Hopkins JA, Leitman SF.

Transfusion. 2012 Jul;52(7):1566-75. doi: 10.1111/j.1537-2995.2011.03488.x. Epub 2011 Dec 29.

28.

Incidence of cardiac arrhythmias in asymptomatic hereditary hemochromatosis subjects with C282Y homozygosity.

Shizukuda Y, Tripodi DJ, Zalos G, Bolan CD, Yau YY, Leitman SF, Waclawiw MA, Rosing DR.

Am J Cardiol. 2012 Mar 15;109(6):856-60. doi: 10.1016/j.amjcard.2011.11.011. Epub 2011 Dec 22.

29.

Blood consult: granulocyte transfusions to treat invasive aspergillosis in a patient with severe aplastic anemia awaiting mismatched hematopoietic progenitor cell transplantation.

O'Donghaile D, Childs RW, Leitman SF.

Blood. 2012 Feb 9;119(6):1353-5. doi: 10.1182/blood-2011-10-345751. Epub 2011 Nov 22. No abstract available.

30.

Changes in left ventricular diastolic function of asymptomatic hereditary hemochromatosis subjects during five years of follow-up.

Shizukuda Y, Tripodi DJ, Sachdev V, Brenneman CL, Sidenko S, St Peter M, Bolan CD, Yau YY, Leitman SF, Waclawiw MA, Rosing DR.

Am J Cardiol. 2011 Dec 15;108(12):1796-800. doi: 10.1016/j.amjcard.2011.07.054. Epub 2011 Sep 16.

PMID:
21925635
31.

Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors.

Olnes MJ, Poon A, Miranda SJ, Pfannes L, Tucker Z, Loeliger K, Padilla-Nash H, Yau YY, Ried T, Leitman SF, Young NS, Sloand EM.

Transfusion. 2012 Mar;52(3):537-41. doi: 10.1111/j.1537-2995.2011.03313.x. Epub 2011 Aug 29.

32.

Leukocyte integrin activation mediates transient neutropenia after G-CSF administration.

Donahue RE, Tuschong L, Bauer TR Jr, Yau YY, Leitman SF, Hickstein DD.

Blood. 2011 Oct 13;118(15):4209-14. doi: 10.1182/blood-2011-06-360461. Epub 2011 Aug 15.

33.

Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

McIver ZA, Melenhorst JJ, Grim A, Naguib N, Weber G, Fellowes V, Khuu H, Stroncek DS, Leitman SF, Battiwalla M, Barrett AJ.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1846-54. doi: 10.1016/j.bbmt.2011.05.017. Epub 2011 May 30.

34.

Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

Mielke S, McIver ZA, Shenoy A, Fellowes V, Khuu H, Stroncek DF, Leitman SF, Childs R, Battiwalla M, Koklanaris E, Haggerty J, Savani BN, Rezvani K, Barrett AJ.

Biol Blood Marrow Transplant. 2011 Dec;17(12):1855-61. doi: 10.1016/j.bbmt.2011.05.019. Epub 2011 May 31.

35.

Accelerated lymphocyte reconstitution and long-term recovery after transplantation of lentiviral-transduced rhesus CD34+ cells mobilized by G-CSF and plerixafor.

Uchida N, Bonifacino A, Krouse AE, Metzger ME, Csako G, Lee-Stroka A, Fasano RM, Leitman SF, Mattapallil JJ, Hsieh MM, Tisdale JF, Donahue RE.

Exp Hematol. 2011 Jul;39(7):795-805. doi: 10.1016/j.exphem.2011.04.002. Epub 2011 Apr 15.

36.

Preparation of granulocyte concentrates by apheresis: collection modalities in the USA.

Strauss RG, Klein HG, Leitman SF, Price TH, Lichtiger B, Martinez F, Reesink HW, Panzer S.

Vox Sang. 2011 May;100(4):426-33. doi: 10.1111/j.1423-0410.2010.01417.x. Epub 2011 Feb 14. No abstract available.

37.

The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.

Heim KF, Fleisher TA, Stroncek DF, Holland SM, Gallin JI, Malech HL, Leitman SF.

Transfusion. 2011 Jun;51(6):1154-62. doi: 10.1111/j.1537-2995.2010.02993.x. Epub 2010 Dec 22.

38.

Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors.

Clayton JA, Vitale S, Kim J, Conry-Cantilena C, Byrne P, Reed GF, Ferris FL 3rd, Leitman SF.

Transfusion. 2011 May;51(5):921-8. doi: 10.1111/j.1537-2995.2010.02948.x. Epub 2010 Nov 23.

39.

Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcome.

Quillen K, Medrano C, Adams S, Peterson B, Hackett J, Leitman SF, Klein HG, Stroncek DF.

Transfusion. 2011 Mar;51(3):504-10. doi: 10.1111/j.1537-2995.2010.02874.x. Epub 2010 Sep 16.

40.

Expression of growth differentiation factor 15 is not elevated in individuals with iron deficiency secondary to volunteer blood donation.

Tanno T, Rabel A, Lee YT, Yau YY, Leitman SF, Miller JL.

Transfusion. 2010 Jul;50(7):1532-5. doi: 10.1111/j.1537-2995.2010.02601.x. Epub 2010 Feb 26.

41.

Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils.

Bryant BJ, Yau YY, Byrne PJ, Stroncek DF, Leitman SF.

Transfusion. 2010 Jun;50(6):1203-9. doi: 10.1111/j.1537-2995.2009.02576.x. Epub 2010 Jan 22.

42.

Genomic scale analysis of racial impact on response to IFN-alpha.

Pos Z, Selleri S, Spivey TL, Wang JK, Liu H, Worschech A, Sabatino M, Monaco A, Leitman SF, Falus A, Wang E, Alter HJ, Marincola FM.

Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):803-8. doi: 10.1073/pnas.0913491107. Epub 2009 Dec 22.

43.

Granulocyte transfusions in severe aplastic anemia: an eleven-year experience.

Quillen K, Wong E, Scheinberg P, Young NS, Walsh TJ, Wu CO, Leitman SF.

Haematologica. 2009 Dec;94(12):1661-8. doi: 10.3324/haematol.2009.010231.

44.

Safety concerns related to use of unapproved needles for accessing implantable venous access devices.

Powers ML, Lublin D, Eby C, Leitman SF, Dynis M, Despotis GJ.

Transfusion. 2009 Sep;49(9):2008-9. doi: 10.1111/j.1537-2995.2009.02296.x. No abstract available.

45.

Does oxidative stress modulate left ventricular diastolic function in asymptomatic subjects with hereditary hemochromatosis?

Shizukuda Y, Bolan CD, Tripodi DJ, Sachdev V, Nguyen TT, Botello G, Yau YY, Sidenko S, Inez E, Ali MI, Waclawiw MA, Leitman SF, Rosing DR.

Echocardiography. 2009 Nov;26(10):1153-8. doi: 10.1111/j.1540-8175.2009.00956.x. Epub 2009 Aug 28.

46.

Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose.

Pulsipher MA, Chitphakdithai P, Logan BR, Leitman SF, Anderlini P, Klein JP, Horowitz MM, Miller JP, King RJ, Confer DL.

Blood. 2009 Sep 24;114(13):2606-16. doi: 10.1182/blood-2009-03-208355. Epub 2009 Jul 16.

47.

Therapeutic plasma exchange reveals a color-coordinated response to cyclosporine-induced microangiopathic hemolytic anemia and rifampin after stem cell transplant.

Bryant BJ, Leitman SF, Klein HG.

Transfusion. 2009 Jul;49(7):1291-2. doi: 10.1111/j.1537-2995.2009.02155.x. No abstract available.

48.

Evaluation of low red blood cell mean corpuscular volume in an apheresis donor population.

Bryant BJ, Hopkins JA, Arceo SM, Leitman SF.

Transfusion. 2009 Sep;49(9):1971-6. doi: 10.1111/j.1537-2995.2009.02207.x. Epub 2009 May 11.

49.

Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.

Quillen K, Byrne P, Yau YY, Leitman SF.

Transfusion. 2009 Mar;49(3):513-8. doi: 10.1111/j.1537-2995.2008.01983.x.

50.

Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program.

Pulsipher MA, Chitphakdithai P, Miller JP, Logan BR, King RJ, Rizzo JD, Leitman SF, Anderlini P, Haagenson MD, Kurian S, Klein JP, Horowitz MM, Confer DL.

Blood. 2009 Apr 9;113(15):3604-11. doi: 10.1182/blood-2008-08-175323. Epub 2009 Feb 3.

Supplemental Content

Loading ...
Support Center